The inhibition of PD-1/PD-L1 pathway may hamper the proliferation of activated effector T cell, causing the tumor evasion from the killing of CTLs, resulting in the weakening of anti-tumor immune response [41]. The gene discussed is CD274; the disease is neoplasm.